172 related articles for article (PubMed ID: 28767722)
61. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
62. Cost-effectiveness of interventions to control cardiovascular diseases and diabetes mellitus in South Asia: a systematic review.
Singh K; Chandrasekaran AM; Bhaumik S; Chattopadhyay K; Gamage AU; Silva P; Roy A; Prabhakaran D; Tandon N
BMJ Open; 2018 Apr; 8(4):e017809. PubMed ID: 29615442
[TBL] [Abstract][Full Text] [Related]
63. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
[TBL] [Abstract][Full Text] [Related]
64. Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study.
Constanti M; Floyd CN; Glover M; Boffa R; Wierzbicki AS; McManus RJ
Hypertension; 2021 Feb; 77(2):682-691. PubMed ID: 33342242
[TBL] [Abstract][Full Text] [Related]
65. Global tobacco prevention and control in relation to a cardiovascular health promotion and disease prevention framework: A narrative review.
Carroll AJ; Labarthe DR; Huffman MD; Hitsman B
Prev Med; 2016 Dec; 93():189-197. PubMed ID: 27717667
[TBL] [Abstract][Full Text] [Related]
66. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
67. A cost-effectiveness analysis of the first federally funded antismoking campaign.
Xu X; Alexander RL; Simpson SA; Goates S; Nonnemaker JM; Davis KC; McAfee T
Am J Prev Med; 2015 Mar; 48(3):318-25. PubMed ID: 25498550
[TBL] [Abstract][Full Text] [Related]
68. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
[TBL] [Abstract][Full Text] [Related]
69. Health Benefits and Cost-Effectiveness of Brief Clinician Tobacco Counseling for Youth and Adults.
Maciosek MV; LaFrance AB; Dehmer SP; McGree DA; Xu Z; Flottemesch TJ; Solberg LI
Ann Fam Med; 2017 Jan; 15(1):37-47. PubMed ID: 28376459
[TBL] [Abstract][Full Text] [Related]
70. The population cost-effectiveness of delivering universal and indicated school-based interventions to prevent the onset of major depression among youth in Australia.
Lee YY; Barendregt JJ; Stockings EA; Ferrari AJ; Whiteford HA; Patton GA; Mihalopoulos C
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):545-564. PubMed ID: 27509769
[TBL] [Abstract][Full Text] [Related]
71. Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.
Cobiac LJ; Magnus A; Barendregt JJ; Carter R; Vos T
BMC Public Health; 2012 Jun; 12():398. PubMed ID: 22657090
[TBL] [Abstract][Full Text] [Related]
72. Cost and Threshold Analysis of the
Weir BW; Cantrell J; Holtgrave DR; Greenberg MS; Kennedy RD; Rath JM; Hair EC; Vallone D
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30082612
[TBL] [Abstract][Full Text] [Related]
73. Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis.
Yang H; Li N; Zhou Y; Xiao Z; Tian H; Hu M; Li S
Drug Des Devel Ther; 2020; 14():157-165. PubMed ID: 32021100
[TBL] [Abstract][Full Text] [Related]
74. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.
Mundt MP; Baker TB; Fraser DL; Smith SS; Piper ME; Fiore MC
Value Health; 2019 Feb; 22(2):177-184. PubMed ID: 30711062
[TBL] [Abstract][Full Text] [Related]
75. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
76. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
[TBL] [Abstract][Full Text] [Related]
77. Estimating the cost and cost-effectiveness for obstetric fistula repair in hospitals in Uganda: a low income country.
Epiu I; Alia G; Mukisa J; Tavrow P; Lamorde M; Kuznik A
Health Policy Plan; 2018 Nov; 33(9):999-1008. PubMed ID: 30252051
[TBL] [Abstract][Full Text] [Related]
78. Cost-effectiveness of risk stratified medication management for reducing premature cardiovascular mortality in Kenya.
Subramanian S; Hilscher R; Gakunga R; Munoz B; Ogola E
PLoS One; 2019; 14(6):e0218256. PubMed ID: 31237910
[TBL] [Abstract][Full Text] [Related]
79. Cost effectiveness of tobacco control policies in Vietnam: the case of population-level interventions.
Higashi H; Truong KD; Barendregt JJ; Nguyen PK; Vuong ML; Nguyen TT; Hoang PT; Wallace AL; Tran TV; Le CQ; Doran CM
Appl Health Econ Health Policy; 2011 May; 9(3):183-96. PubMed ID: 21506624
[TBL] [Abstract][Full Text] [Related]
80. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control.
Cirera L; Galatas B; Alonso S; Paaijmans K; Mamuquele M; Martí-Soler H; Guinovart C; Munguambe H; Luis F; Nhantumbo H; Montañà J; Bassat Q; Candrinho B; Rabinovich R; Macete E; Aide P; Alonso P; Saúte F; Sicuri E
PLoS One; 2020; 15(7):e0235631. PubMed ID: 32628741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
